This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Caprelsa

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Caprelsa Means in Everyday Medical Language

Caprelsa, also known by its generic name vandetanib, is a medicine used to treat a specific type of thyroid cancer called medullary thyroid cancer. This cancer starts in the cells of the thyroid gland that produce the hormone calcitonin. Caprelsa is mainly used when the cancer is advanced—meaning it cannot be removed by surgery or has spread to other parts of the body. It is a targeted therapy that works by blocking certain proteins inside cancer cells that help them grow and survive. It also stops the growth of new blood vessels that tumors need to grow, which can slow or stop cancer progression.

Why Caprelsa Can Matter in Cancer Care

For patients whose medullary thyroid cancer cannot be treated with surgery alone, Caprelsa offers an important treatment option. It is often prescribed when other treatments are not suitable or have not worked. While Caprelsa is not a cure, it may help control the cancer and improve quality of life by slowing tumor growth. Because it targets specific cancer cell processes, it is different from traditional chemotherapy, which affects many rapidly dividing cells. This targeted approach can mean different side effects and monitoring needs.

What Patients Might See or Hear About Caprelsa

Patients may hear the name Caprelsa or vandetanib during discussions about treatment choices, clinical trials, or when reviewing drug information sheets. It may appear in medical reports or treatment plans when the care team is considering or using this drug. Doctors and nurses usually explain how Caprelsa works, what side effects to expect, and how the treatment will be given. Common questions include how long treatment lasts, what monitoring is needed, and how to manage side effects. Understanding that Caprelsa is not a cure but a treatment to help control cancer can help patients feel more informed.

Where Caprelsa May Appear in Care and Information

Caprelsa may be mentioned in various places such as your medical record, treatment plan, visit notes, or clinical trial information. It is also described on drug information pages and cancer resource websites. Seeing the term means your care team is considering or using this medicine as part of your cancer treatment. It is helpful to ask your care team how Caprelsa fits into your overall care plan and what to expect during treatment.

What Caprelsa Does Not Automatically Mean

Seeing Caprelsa mentioned does not mean the cancer will definitely respond to the treatment or that surgery is no longer an option in all cases. Each patient’s situation is unique, and the decision to use Caprelsa depends on many factors. It also does not mean the cancer is cured. Caprelsa is a treatment that may help control the disease and improve quality of life but is not a guaranteed cure.

Common Questions to Ask Your Care Team

Patients and caregivers may want to ask about how Caprelsa works, what side effects to watch for, how the drug is taken, and how long treatment will last. It is also important to ask about monitoring during treatment, possible drug interactions, and what to do if side effects occur. Talking openly with your care team can help you understand how Caprelsa fits into your treatment and what support is available.

Understanding Caprelsa in Context

Caprelsa is part of a group of medicines called tyrosine kinase inhibitors, which target specific proteins involved in cancer growth. It is also known by other names such as vandetanib and ZD6474. Knowing these different names can help avoid confusion when reading medical reports or drug information. Caprelsa is approved mainly for medullary thyroid cancer but is being studied for other cancers as well.

Important Safety and Next Steps

This information is meant to educate and support patients and caregivers. It does not replace advice from your doctor or healthcare team. If you or a loved one is prescribed Caprelsa, the best next step is to discuss it with your cancer care team. They can provide personalized information about whether this drug is appropriate, how it will be given, and what follow-up care is needed. Understanding more about Caprelsa can help you feel more confident and involved in your treatment decisions.

Sources

Public source information used for this glossary entry includes: